| scholarly article | Q13442814 |
| P50 | author | Bjørn Hofmann | Q39063740 |
| Lars Sandman | Q79458431 | ||
| P2093 | author name string | Ken Bond | |
| P2860 | cites work | "Ain't no one here but us social forces": constructing the professional responsibility of engineers | Q84669200 |
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Values in Health Policy - A Concept Analysis | Q28080286 | ||
| Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials | Q28564011 | ||
| Measuring effectiveness | Q30048233 | ||
| Obesity as a Socially Defined Disease: Philosophical Considerations and Implications for Policy and Care. | Q30373227 | ||
| Social value judgments in healthcare: a philosophical critique. | Q30419925 | ||
| Value judgments in the analysis and synthesis of evidence | Q33333716 | ||
| On the value-ladenness of technology in medicine | Q34472721 | ||
| Can Technological Artefacts Be Moral Agents? | Q35243415 | ||
| Framework for systematic identification of ethical aspects of healthcare technologies: the SBU approach | Q35949744 | ||
| Ethical analysis in HTA of complex health interventions | Q35966688 | ||
| Health technology assessment: a comprehensive framework for evidence-based recommendations in Ontario | Q37444256 | ||
| Patients' perspectives in health technology assessment: a route to robust evidence and fair deliberation | Q37768242 | ||
| Ethical issues with colorectal cancer screening-a systematic review | Q39057737 | ||
| Complex health care interventions: Characteristics relevant for ethical analysis in health technology assessment | Q39619021 | ||
| Health technology assessment and ill-structured problems: a case study concerning the drug mebeverine | Q40202118 | ||
| Limits to human enhancement: nature, disease, therapy or betterment? | Q42374492 | ||
| Accountability for reasonableness | Q42769474 | ||
| HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUES. | Q47405653 | ||
| Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes | Q47977244 | ||
| Harmonization of ethics in health technology assessment: a revision of the Socratic approach | Q48086584 | ||
| DEVELOPMENTS IN VALUE FRAMEWORKS TO INFORM THE ALLOCATION OF HEALTHCARE RESOURCES. | Q48639504 | ||
| Revealing and acknowledging value judgments in health technology assessment. | Q50943150 | ||
| The HTA core model: a novel method for producing and reporting health technology assessments. | Q53181827 | ||
| A history of ISTAHC. A personal perspective on its first 10 years. International Society of Technology Assessment in Health Care. | Q53358695 | ||
| Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe | Q56018116 | ||
| Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences | Q58476451 | ||
| Summary report of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions | Q74255624 | ||
| What is value in health care? | Q82807569 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 957-965 | |
| P577 | publication date | 2018-04-03 | |
| P1433 | published in | Journal of Evaluation in Clinical Practice | Q15767649 |
| P1476 | title | Evaluating facts and facting evaluations: On the fact-value relationship in HTA | |
| P478 | volume | 24 |
| Q92920281 | Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes |
| Q104134108 | Core competencies for ethics experts in health technology assessment |
| Q98195651 | Principles for deliberative processes in health technology assessment |
Search more.